These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9139496)

  • 41. Efficacy of hepatitis B vaccine in chimpanzees given transfusions of highly infective blood.
    Karasawa T; Shikata T; Abe K; Horiuchi R; Takahashi T; Yoshihara N; Mayumi M; Suzuki H; Oda T
    J Infect Dis; 1983 Feb; 147(2):327-35. PubMed ID: 6827148
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amino acid substitutions Q129N and T131N/M133T in hepatitis B surface antigen (HBsAg) interfere with the immunogenicity of the corresponding HBsAg or viral replication ability.
    Kang Y; Li F; Guo H; Yang S; Zhang Y; Zhu H; Wang J; Mao R; Qin Y; Xu J; Chen X; Wu C; Zhang J
    Virus Res; 2018 Sep; 257():33-39. PubMed ID: 30179704
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Properties of recombinant hepatitis B vaccine.
    Ohmura T; Ohmizu A; Sumi A; Ohtani W; Uemura Y; Arimura H; Nishida M; Kohama Y; Okabe M; Mimura T
    Biochem Biophys Res Commun; 1987 Dec; 149(3):1172-8. PubMed ID: 2962578
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lack of genetic restriction by a potential anti-idiotype vaccine for type B viral hepatitis.
    Kennedy RC; Eichberg JW; Dreesman GR
    Virology; 1986 Jan; 148(2):369-74. PubMed ID: 3484564
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.
    Xiang ZQ; Yang Y; Wilson JM; Ertl HC
    Virology; 1996 May; 219(1):220-7. PubMed ID: 8623532
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A 20,500-Dalton protein is coded by region E3 of subgroup B but not subgroup C human adenoviruses.
    Hawkins LK; Wold WS
    Virology; 1995 Apr; 208(1):226-33. PubMed ID: 11831704
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Construction and characterization of adenovirus co-expressing hepatitis B virus surface antigen and interleukin-6.
    Lindley T; Virk KP; Ronchetti-Blume M; Goldberg K; Lee SG; Eichberg JW; Hung PP; Cheng SM
    Gene; 1994 Jan; 138(1-2):165-70. PubMed ID: 8125296
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen.
    Cooreman MP; Leroux-Roels G; Paulij WP
    J Biomed Sci; 2001; 8(3):237-47. PubMed ID: 11385295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers.
    Dusheiko GM; Hoofnagle JH; Cooksley WG; James SP; Jones EA
    J Clin Invest; 1983 May; 71(5):1104-13. PubMed ID: 6602149
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endogenous expression of E1A in human cells enhances the effect of adenovirus E3 on class I major histocompatibility complex antigen expression.
    Routes JM; Metz BA; Cook JL
    J Virol; 1993 Jun; 67(6):3176-81. PubMed ID: 8497046
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of systemic and mucosal immune responses in cotton rats immunized with human adenovirus type 5 recombinants expressing the full and truncated forms of bovine herpesvirus type 1 glycoprotein gD.
    Mittal SK; Papp Z; Tikoo SK; Baca-Estrada ME; Yoo D; Benko M; Babiuk LA
    Virology; 1996 Aug; 222(2):299-309. PubMed ID: 8806514
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deletion of the E3-6.7K/gp19K region reduces the persistence of wild-type adenovirus in a permissive tumor model in Syrian hamsters.
    Bortolanza S; Bunuales M; Alzuguren P; Lamas O; Aldabe R; Prieto J; Hernandez-Alcoceba R
    Cancer Gene Ther; 2009 Sep; 16(9):703-12. PubMed ID: 19229289
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A vectored measles virus induces hepatitis B surface antigen antibodies while protecting macaques against measles virus challenge.
    del Valle JR; Devaux P; Hodge G; Wegner NJ; McChesney MB; Cattaneo R
    J Virol; 2007 Oct; 81(19):10597-605. PubMed ID: 17634218
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel hepatitis B virus variant S 129 (Gln-->Leu): lack of correlation between antigenicity and immunogenicity.
    Wu L; He JW; Yao X; Li HM; Wen YM
    J Med Virol; 1999 Dec; 59(4):424-30. PubMed ID: 10534722
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparing the immunogenicity of hepatitis B virus S gene variants by DNA immunization.
    Wu L; Yuan ZH; Liu F; Waters JA; Wen YM
    Viral Immunol; 2001; 14(4):359-67. PubMed ID: 11792065
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of HBV surface antigen or HIV envelope protein using recombinant adenovirus vectors.
    Hung PP; Morin JE; Lubeck MD; Barton JE; Molnar-Kimber KL; Mason BB; Dheer SK; Jarocki-Witek V; Kostek B; Zandle G
    Nat Immun Cell Growth Regul; 1988; 7(3):135-43. PubMed ID: 3173369
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunogenicity and safety in newborns of a new recombinant hepatitis B vaccine containing the S and pre-S2 antigens.
    Soulié JC; Devillier P; Santarelli J; Goudeau A; Vermeulen P; Guellier M; Saliou P; Hillion AM; Tron F; Huchet J
    Vaccine; 1991 Aug; 9(8):545-8. PubMed ID: 1837646
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis B vaccination.
    Romanò L; Paladini S; Galli C; Raimondo G; Pollicino T; Zanetti AR
    Hum Vaccin Immunother; 2015; 11(1):53-7. PubMed ID: 25483515
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Poliovirus recombinants expressing hepatitis B virus antigens elicited a humoral immune response in susceptible mice.
    Yim TJ; Tang S; Andino R
    Virology; 1996 Apr; 218(1):61-70. PubMed ID: 8615042
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting murine immune responses to selected T cell- or antibody-defined determinants of the hepatitis B surface antigen by plasmid DNA vaccines encoding chimeric antigen.
    Schirmbeck R; Zheng X; Roggendorf M; Geissler M; Chisari FV; Reimann J; Lu M
    J Immunol; 2001 Jan; 166(2):1405-13. PubMed ID: 11145726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.